Advanced Search

Study Preview



Study Title and Description

Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant.



Key Questions Addressed
3 In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant.
Author Refaie AF., Mahmoud KM., Ismail AM., Sheashaa HA., Kamal AI., Ghoneim MA.
Country Department of Nephrology, Urology and Nephrology Center, Mansoura 35516, Egypt. ayman_refaie@yahoo.com
Year 2011
Numbers Pubmed ID: 21967254
2647 (internal)

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Comparative Effectiveness of Regimens


Results & Comparisons

No Results found.